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The mean PTV homogeneity index (HI) was 0.14±0.04 for SA 
and 0.09±0.03 for DA. For the OAR sparing, there was no 
significant difference between the SA and DA. A significantly 
difference was observed in the number of MUs and the 
treatment time, SA presents a reduction of 10.3% and 24.5% 
respectively. 
 
Conclusion: SA showed no significantly difference in PTV 
coverage and OAR sparing compared with DA, however, the 
CI and HI of DA were better than those of SA. SA improved 
the greater treatment efficiency, and achieved less MUs 
number. In order to reduce patient treatment time, SA is 
worth to consider. 
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Purpose or Objective: The modulated arc (mARC) is a VMAT-
like rotational technique specifically designed for “burst 
mode” delivery of high dose rates. Only few studies have 
assessed the performance of this radiotherapy modality, and 
it is unclear how efficient it will prove for target volumes of 
high vs. low complexity. We therefore present a planning and 
delivery study for two frequent clinical applications: a 
relatively simple target volume for prostate cancer without 
lymph node involvement and a highly complex target volume 
for hypopharynx cancer. In each case, plan quality, 
treatment time and scattered dose are compared for mARC 
vs. IMRT using flat or flattening-filter-free (FFF) beams. 
 
Material and Methods: Contours were retrospectively 
created for 10 prostate cancer patients and 8 head-and-neck 
cancer patients treated at our clinic. IMRT plans were set up 
using 11 beams and 55 segments. mARC plans for both 
energies were made using one rotation for prostate and two 
rotations for head-and-neck patients, with 4° arclets of 
spaced equidistantly every 8°. The Varian Eclipse treatment 
planning system with the AAA dose algorithm and a 2.5 mm 
dose grid was used for all plans. Plan quality was assessed 
using PTV coverage and sparing of organs at risk. All plans 
were delivered on an anthropomorphic phantom, where 
scattered dose was measured with thermoluminescent 
dosimeters (TLDs), and treatment times were recorded. 
 
Results: All plans were visually assessed by a senior radiation 
oncologist and were deemed acceptable for treatment. Only 
few significant differences were found for PTV coverage and 
OAR sparing. For prostate cancer plans, no significant 
differences in OAR sparing were found except for the 
bladder, which was better spared by mARC than IMRT for 
both beam energies. For head-and-neck cancer cases, the 
mARC technique achieved a higher index of conformity and 
better sparing of the parotids.  
 
 
 
While differences in plan quality were minor, treatment 
times could be drastically reduced by the combination of 
mARC with FFF beams.e average treatment times for 
prostate cancer were reduced from 7 min for 6 MV IMRT to 2-
3 min for FFF mARC. For the complex head-and-neck target 
volume, times were again reduced from ca. 9 min (IMRT, 6 
MV) to 5:30 min (mARC, FFF 7 MV), even though FFF 7 MV 
required significantly more monitor units than 6 MV plans.  
The scattered dose was considerably lower for the mARC as 
compared with IMRT for all plans. For the prostate, scattered 
dose was further reduced by the FFF beam energy. For 
hypopharynx cancer, this effect was partially obscured by the 
higher monitor units. 
 
 
Conclusion: Target volumes of high and of low complexity 
were analysed in this work. For both scenarios, the mARC 
technique achieved plan qualities comparable or even better 
than for IMRT, with a considerable reduction in treatment 
time (ca. 64 % for prostate and 40 % for hypopharynx) and 
scattered dose. 
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Purpose or Objective: To investigate the feasibility of 
hippocampal-sparing radiotherapy for glioblastoma patients 
using volumetric modulated arc therapy (VMAT). Since 
neurocognitive decline has been associated with hippocampal 
dose, hippocampal sparing could potentially improve 
neurological outcome of patients undergoing cranial 
irradiation. 
 
Material and Methods: Datasets of 27 patients who received 
3D-CRT for glioblastoma were included in this planning study. 
Dose distributions for the 3D-CRT plans were calculated in 
Elekta Oncentra Masterplan with a pencil beam algorithm. 
VMAT plans were optimized using the research TPS Hyperion 
V2.44 (equivalent to Elekta Monaco 5.1) which relies on 
Monte Carlo dose calculation. It was attempted to reduce the 
dose to the contralateral hippocampus as much as possible 
without compromising other treatment parameters such as 
target coverage, homogeneity index, conformity index and 
dose to other organs at risk including brain stem, chiasm, 
optic nerve and lenses. Parameters for both techniques were 
compared applying the Wilcoxon signed-rank test. The 
influence of tumor localization on hippocampal dose 
exposure was investigated with the Mann-Whitney U test. The 
correlation between PTV size and hippocampal dose was 
assessed with Spearman’s rank correlation coefficient. 
 
Results: With VMAT compared to 3D-CRT, the median 
reduction of the mean contralateral hippocampus dose was 
56% (p<0.01). Other treatment parameters could be improved 
or at least be kept stable. Particularly, the median V30Gy of 
the brain was reduced from 58.7% to 48.2% (p<0.01). The 
median homogeneity index improved from 0.18 for 3D-CRT to 
0.15 for VMAT (p<0.01), the median conformity index from 
0.70 to 0.80 (p<0.01). For VMAT, a smaller PTV size 
correlated with improved hippocampal sparing (p=0.01). A 
